Efficacy and safety of anti-TNF alpha therapies in ankilosing spondylitis patients:: 2 years follow-up

被引：0
|
作者：
Erra, A [1 ]
Moreno, E [1 ]
Leon, Y [1 ]
Tomas, C [1 ]
Barceló, P [1 ]
Marsal, S [1 ]
机构：
[1] Univ Barcelona, Hosp Gen Valle Hebron, Barcelona, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 404
页数：1
相关论文
共 50 条
  • [31] Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab - Results of a follow-up after one year of readministration
    Baraliakos, X
    Listing, J
    Brandt, J
    Alten, R
    Burmester, G
    Gromnika-Ihle, E
    Kellner, H
    Schneider, M
    Soerensen, H
    Zeidler, H
    Haibel, H
    Rudwaleit, M
    Sieper, J
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 323 - +
  • [32] Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies
    Gonzalez-Gay, Miguel A.
    Agudo, Mario
    MEDICINA CLINICA, 2010, 134 (15): : 684 - 685
  • [33] An Exploration of the Impact of Anti-TNF alpha Medication on Exercise Behaviour in Patients with Ankylosing Spondylitis
    Stockdale, Jennifer
    Selfe, James
    Roddam, Hazel
    MUSCULOSKELETAL CARE, 2014, 12 (03) : 150 - 159
  • [34] Efficacy and Safety of ANTI-TNF ALPHA in BEHCET Disease: A International Multicenter Registry of 122 Patients.
    Vallet, Helene
    Riviere, Sophie
    Deroux, Alban
    Moulis, Guillaume
    Addimanda, Olga
    Salvarani, Carlo
    Lambert, Marc
    Bielfeld, Philip
    Seve, Pascal
    Sibilia, Jean
    Fraison, Jean Baptiste
    Schoindre, Yoland
    Marie, Isabelle
    Perard, Laurent
    Papo, Thomas
    Sene, Damien
    Leroux, Gaelle
    Royant, Valerie
    Perlat, Antoinette
    Mariette, Xavier
    Lidove, Olivier
    Fain, Olivier
    De Moreuil, Claire
    Blaison, Gilles
    Phuc LE Hoang
    Hachulla, Eric
    Wechsler, Bertrand
    Bodaghi, Barham
    Cacoub, Patrice
    Saadoun, David
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1204 - S1205
  • [35] Safety, efficacy, and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-TNF
    Ben-Horin, S.
    Ungar, B.
    Kopylov, U.
    Lahat, A.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Peled, Y.
    Eliakim, R.
    Del Tedesco, E.
    Paul, S.
    Roblin, X.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S493 - S493
  • [36] Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
    P Tynjälä
    V Honkanen
    K Aalto
    T Levälampi
    Pediatric Rheumatology, 6 (Suppl 1)
  • [37] SAFETY, EFFICACY AND PHARMACOKINETICS OF VEDOLIZUMAB IN PATIENTS WITH SIMULTANEOUS EXPOSURE TO AN ANTI-TNF
    Ben-Horin, Shomron
    Ungar, Bella
    Kopylov, Uri
    Lahat, Adi
    Yavzori, Miri
    Fudim, Ella
    Picard, Orit
    Eliakim, Abraham R.
    Del Tedesco, Emilie
    Paul, Stephane
    Roblin, Xavier
    GASTROENTEROLOGY, 2018, 154 (06) : S839 - S840
  • [38] BIOSIMILAR INFLIXIMAB IN ANTI-TNF NAIVE IBD PATIENTS AND ONE-YEAR CLINICAL FOLLOW-UP
    Kolar, Martin
    Duricova, Dana
    Bortlik, Martin
    Hruba, Veronika
    Machkova, Nadezda
    Mitrova, Katarina
    Lukas, Martin
    Malickova, Karin
    Lukas, Milan
    GASTROENTEROLOGY, 2017, 152 (05) : S398 - S399
  • [39] Azathioprine and anti-TNFα therapies in Crohn's disease:: a review of pharmacology, clinical efficacy and safety
    Arnott, IDR
    Watts, D
    Satsangi, J
    PHARMACOLOGICAL RESEARCH, 2003, 47 (01) : 1 - 10
  • [40] How Could Be Used the Autoantibodies Against Anti-TNF Agents in Clinical Practice? Two Years Follow-Up Study
    Cosan, Fulya
    Cetin, Esin Aktas
    Gazioglu, Sema Bilgic
    Yazici, Ayten
    Yilmazer, Baris
    Cefle, Ayse
    Deniz, Gunnur
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S34 - S34
12345